DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $14.00 by Analysts at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target reduced by research analysts at Barrington Research from $18.00 to $14.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price objective would suggest a potential upside of 25.22% from the stock’s current price.

XRAY has been the subject of a number of other reports. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a research report on Tuesday, October 28th. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Stifel Nicolaus set a $13.00 target price on DENTSPLY SIRONA in a research note on Thursday. Wall Street Zen downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. Finally, Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Two equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $16.08.

DENTSPLY SIRONA Trading Up 1.5%

NASDAQ XRAY opened at $11.18 on Monday. The business’s fifty day moving average is $12.98 and its 200-day moving average is $14.49. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The stock has a market capitalization of $2.23 billion, a price-to-earnings ratio of -2.36, a PEG ratio of 0.81 and a beta of 1.00. DENTSPLY SIRONA has a one year low of $10.69 and a one year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. During the same quarter in the previous year, the company posted $0.50 EPS. DENTSPLY SIRONA’s quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Equities research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current year.

Institutional Trading of DENTSPLY SIRONA

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Brooklyn Investment Group purchased a new stake in DENTSPLY SIRONA during the 1st quarter worth about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of DENTSPLY SIRONA during the first quarter valued at about $26,000. Trust Co. of Toledo NA OH purchased a new stake in shares of DENTSPLY SIRONA in the second quarter worth about $27,000. Parkside Financial Bank & Trust boosted its position in shares of DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,477 shares during the period. Finally, Caitong International Asset Management Co. Ltd grew its stake in DENTSPLY SIRONA by 8,003.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 2,241 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.